Abiopharma

Brookdale Senior Living Inc. - Brookdale Announces 2026 Investor Day and Webcast

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

Brookdale Announces 2026 Investor Day and Webcast

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

BridgeBio Prices Offering of $550 Million Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

アジーナス、BOT+BALを推進し、米国での製造体制を強化するため、ザイダス・ライフサイエンスとの1億4100万ドル規模の戦略的提携を締結